The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5- a ]-pyrimidine: A corticotropin-releasing factor (hCRF 1 ) antagonist
- 1 January 2000
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 8 (1), 181-189
- https://doi.org/10.1016/s0968-0896(99)00271-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Corticotropin‐Releasing Hormone and InflammationAnnals of the New York Academy of Sciences, 1998
- Chapter 5. Corticotropin-Releasing Hormone (CRH) Receptors and the Discovery of Selective Non-Peptide CRH1 AntagonistsPublished by Elsevier BV ,1997
- The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated InflammationNew England Journal of Medicine, 1995
- Increased Numbers of Corticotropin-Releasing Hormone Expressing Neurons in the Hypothalamic Paraventricular Nucleus of Depressed PatientsNeuroendocrinology, 1994
- Elevated CSF CRF in suicide victimsBiological Psychiatry, 1989
- CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depressionBiological Psychiatry, 1988
- CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophreniaAmerican Journal of Psychiatry, 1987
- Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic studyJournal of Neuroscience, 1985
- Characterization of rat hypothalamic corticotropin-releasing factor.Proceedings of the National Academy of Sciences of the United States of America, 1983
- Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-EndorphinScience, 1981